Reducing the spread of antibiotic-resistant infections from hospitals to communities

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the effectiveness of a bundle of interventions designed to reduce the transmission of Carbapenem-resistant Enterobacteriaceae (CRE) from hospitalized patients to their households and communities. The study will involve a cluster randomized controlled trial where districts in two provinces will be assigned to either an intervention or control group. Interventions include education on hygiene practices, communication strategies, and reducing antibiotic use, developed in collaboration with local health authorities. The impact of these interventions will be evaluated through screening for CRE in household members, livestock, and the environment, alongside surveys to assess knowledge and practices related to health and hygiene.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients under 2 years old at the selected hospital are highly appreciated to join the study.

Exclusion Criteria:

* Patients not from the selected hospital and individuals outside the selected province

Where it's running

• Thai Binh Pediatric Hospital
  Thái Bình, Thai Binh, Vietnam Recruiting

Study contacts

• Principal investigator: Mattias Larsson, MD — Karolinska Institutet
• Study coordinator: Phuc Pham-Duc, MD, PhD
• Email: pdp@huph.edu.vn
• Phone: 84904049969

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Aztreonam-Avibactam in Immunocompromised Patients with Multidrug-Resistant Infections

  This study tests how well and how safely aztreonam-avibactam works in adults with weakened immune systems who have highly resistant Enterobacterales infections.

  Recruiting Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno · Buenos Aires, City of Buenos Aires · NCT07890480

• Jet versus vibrating mesh inhalation of polymyxin B for ventilated patients with carbapenem‑resistant Gram‑negative pneumonia

  This trial tests whether jet nebulizers or vibrating mesh nebulizers deliver inhaled polymyxin B more effectively for mechanically ventilated patients with carbapenem‑resistant Gram‑negative pneumonia.

  Recruiting Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07086391

• Using chlorination to reduce infections in newborns

  This study is testing if using chlorinated water in hospitals can help reduce infections in mothers and newborns in western Kenya.

  Recruiting University of California, Berkeley · Berkeley, California and 1 other locations · NCT06824350

• Using Colistimethate Sodium to Treat Infections from Carbapenem-Resistant Bacteria

  This study is testing if colistimethate sodium can help hospitalized patients with infections from tough-to-treat bacteria feel better compared to standard treatments.

  Recruiting at 15 sites Southeast University, China · Hefei, Anhui and 14 other locations · NCT06051513

• Early treatment with targeted antibiotics for severe infections using rapid diagnostics

  This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.

  Recruiting at 21 sites Phase 4 National University of Singapore · Vellore and 20 other locations · NCT05979545

• Assessing H. pylori infection rates and antibiotic resistance in Germany

  This study is trying to find out how common H. pylori infections are in Germany and if the bacteria are resistant to antibiotics, so doctors can better treat patients.

  Recruiting Technical University of Munich · Munich · NCT05561504

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.